B.1.617.2 enters and fuses lung cells with increased efficiency

The Delta variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), B.1.617.2, emerged in India and has spread to over 80 countries. B.…

P681 mutations within the polybasic motif of spike dictate fusogenicity and syncytia formation of SARS CoV-2 variants

Molecular variants of SARS-CoV-2: antigenic properties and current vaccine efficacy

Frontiers Novel receptor, mutation, vaccine, and establishment of coping mode for SARS-CoV-2: current status and future

Evolution of Sequence and Structure of SARS-CoV-2 Spike Protein: A Dynamic Perspective

P681 mutations within the polybasic motif of spike dictate fusogenicity and syncytia formation of SARS CoV-2 variants

Multivalent S2-based vaccines provide broad protection against SARS-CoV-2 variants of concern and pangolin coronaviruses - eBioMedicine

Integrin/TGF-β1 inhibitor GLPG-0187 blocks SARS-CoV-2 Delta and Omicron pseudovirus infection of airway epithelial cells which could attenuate disease severity

Monoclonal antibodies for COVID-19 therapy and SARS-CoV-2 detection, Journal of Biomedical Science

Covid-19: virology, variants, and vaccines

The Omicron variant is highly resistant against antibody-mediated neutralization – implications for control of the COVID-19 pandemic

Updates on COVID-19 Variants – National Collaborating Centre for Infectious Diseases

Delta variant exhibits immune evasion, enhanced cell entry, and augmented syncytium formation